These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19881229)

  • 1. Standardized prevalence ratios for chronic hepatitis C virus infection among adult Japanese hemodialysis patients.
    Ohsawa M; Kato K; Itai K; Tanno K; Fujishima Y; Konda R; Okayama A; Abe K; Suzuki K; Nakamura M; Onoda T; Kawamura K; Sakata K; Akiba T; Fujioka T
    J Epidemiol; 2010; 20(1):30-9. PubMed ID: 19881229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients.
    Wong XZ; Gan CC; Mohamed R; Yahya R; Ganapathy S; Tan SS; Lim SK
    BMC Nephrol; 2020 Nov; 21(1):480. PubMed ID: 33187498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients.
    Gohar SA; Khalil RY; Elaish NM; Khedr EM; Ahmed MS
    J Egypt Public Health Assoc; 1995; 70(5-6):465-84. PubMed ID: 17214170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characterization of hepatitis C virus in hemodialysis patients.
    Morikawa T; Nakata K; Hamasaki K; Tsuruta S; Kato Y; Nakao K; Ohtsubo T; Eguchi K
    Intern Med; 1999 Aug; 38(8):626-31. PubMed ID: 10440497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients.
    Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV
    Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ENA antibody profile in hepatitis C patients undergoing hemodialysis.
    Batchoun RG; Al-Najdawi MA; Al-Taamary S
    Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):682-8. PubMed ID: 21743211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit.
    Saxena AK; Panhotra BR
    Med Princ Pract; 2004; 13(3):129-35. PubMed ID: 15073424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns in the prevalence of hepatitis C virus infection at the start of hemodialysis in Japan.
    Iwasa Y; Otsubo S; Sugi O; Sato K; Asamiya Y; Eguchi A; Iwasaki T; Matsuda N; Kikuchi K; Ikebe N; Miwa N; Kimata N; Uchida K; Uchida S; Nitta K; Akiba T
    Clin Exp Nephrol; 2008 Feb; 12(1):53-7. PubMed ID: 18175054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.
    Jadoul M; Bieber BA; Martin P; Akiba T; Nwankwo C; Arduino JM; Goodkin DA; Pisoni RL
    Kidney Int; 2019 Apr; 95(4):939-947. PubMed ID: 30904068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection by hepatitis C virus in patients on hemodialysis: prevalence and risk factors].
    Leão JR; Pace FH; Chebli JM
    Arq Gastroenterol; 2010; 47(1):28-34. PubMed ID: 20520972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of HCV core antigen ELISA in the screening for hepatitis C virus infection in patients on hemodialysis.
    Reddy AK; Dakshinamurty KV; Lakshmi V
    Indian J Med Microbiol; 2006 Jan; 24(1):55-7. PubMed ID: 16505558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult HBV infection status among chronic hepatitis C and hemodialysis patients in Northeastern Egypt: regional and national overview.
    Mandour M; Nemr N; Shehata A; Kishk R; Badran D; Hawass N
    Rev Soc Bras Med Trop; 2015; 48(3):258-64. PubMed ID: 26108002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].
    Padrone M; Corallini O; Cocozzella D; Malca M; Borzi S; Barrio M; Adrover RE; Cuffini AM; Gomez C; Giamona AM; Brawlasky G; Newmann P; Dell Amo M; Fraquelli E; Curciarello JO
    Acta Gastroenterol Latinoam; 1999; 29(3):91-4. PubMed ID: 10533653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil.
    Silva LK; Silva MB; Rodart IF; Lopes GB; Costa FQ; Melo ME; Gusmão E; Reis MG
    Braz J Med Biol Res; 2006 May; 39(5):595-602. PubMed ID: 16648896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients.
    Ponnuvel S; Fletcher GJ; Anantharam R; Varughese S; David VG; Abraham P
    PLoS One; 2021; 16(4):e0250263. PubMed ID: 33886631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus infection and non-hemodialysis patients with hepatitis cirrhosis.
    Ng YY; Lin CC; Wu SC; Hwang SJ; Ho CH; Yang WC; Lee SD
    Clin Nephrol; 2002 Apr; 57(4):289-95. PubMed ID: 12005245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of HCV infection in patients on haemodialysis: survey by antibody and core antigen detection.
    Reddy AK; Murthy KV; Lakshmi V
    Indian J Med Microbiol; 2005 Apr; 23(2):106-10. PubMed ID: 15928439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver disease-related mortality in hemodialysis patients.
    Ohsawa M; Kato K; Tanno K; Itai K; Fujishima Y; Okayama A; Turin TC; Onoda T; Suzuki K; Nakamura M; Kawamura K; Akiba T; Sakata K; Fujioka T
    J Epidemiol; 2011; 21(6):491-9. PubMed ID: 22001541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.